ASGCT publishes four journals, landscape reports, and more

Molecular Therapy Family Landscape Report

What We Publish

Get the latest on cell & gene therapy:

  • Molecular Therapy family of journals: 4 journals, 24 issues per year, plus 2 bonus abstract issues—FREE for members!
  • Landscape Report: Only field-wide report on therapeutics, clinical targets, developer progress, and more
  • ASGCT blog
  • The Vector: Updates on ASGCT and the field
  • The Advocate: Regulatory policy, patient access, and more advocacy topics
  • ASGCT Podcast Network.

Molecular Therapy Family

Molecular Therapy

MT is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology.

Molecular Therapy Methods & Clinical Development

Molecular Therapy Methods & Clinical Development focuses on advances in cell and gene therapy and how they are translated and applied in the clinical setting.

Molecular Therapy Nucleic Acids

Molecular Therapy Nucleic Acids publishes top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease.

Molecular Therapy Oncology

Molecular Therapy Oncology focuses on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.

ASGCT Publications

Gene, Cell, & RNA Therapy Landscape Report

The Landscape report, created in partnership with Informa Pharma Intelligence, is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

ASGCT Podcast Network

Listen to luminaries in the worlds of cell and gene therapyon ASGCT's inagural program, Giants of Gene Therapy. Subscribe to the channel wherever you listen to podcasts.

The Vector Newsletter

The Vector connects ASGCT Members with the latest news from the Society and the gene and cell therapy field. Issues are published on the second Thursday of each month.

The Advocate Newsletter

Policy and advocacy professionals subscribe to The Advocate for the latest updates from ASGCT on regulatory policy, patient access, and other advocacy topics. Anyone interested can sign up for monthly emails. 


The blog highlights ASGCT initiatives and events and provides insights on the state of gene and cell therapy industry. 


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.